Department of Medical Administration NH. Health Commission of the people’s Republic of C. [Guidelines for diagnosis and treatment of primary liver cancer in China (2019 edition)]. Zhonghua Gan Zang Bing Za Zhi. 2020;28(2):112–28.

Google Scholar 

Breedis C, Young G. The blood supply of neoplasms in the liver. Am J Pathol. 1954;30(5):969–77.

CAS  PubMed  PubMed Central  Google Scholar 

Qin S, Bai Y, Lim HY, et al. Randomized, multicenter, open-label study of oxaliplatin plus fluorouracil/leucovorin versus doxorubicin as palliative chemotherapy in patients with advanced hepatocellular carcinoma from Asia. J Clin Oncol. 2013;31(28):3501–8.

Article  CAS  PubMed  Google Scholar 

Yan L, Lin J, Ke K, et al. A meta-analysis comparing hepatic arterial infusion chemotherapy and sorafenib for advanced hepatocellular carcinoma. Transl Cancer Res. 2022;11(1):99–112.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zheng K, Zhu X, Fu S, et al. Sorafenib Plus hepatic arterial infusion Chemotherapy versus Sorafenib for Hepatocellular Carcinoma with Major Portal Vein Tumor thrombosis: a Randomized Trial. Radiology. 2022;303(2):455–64.

Article  PubMed  Google Scholar 

He M, Li Q, Zou R, et al. Sorafenib Plus hepatic arterial infusion of Oxaliplatin, Fluorouracil, and Leucovorin vs Sorafenib alone for Hepatocellular Carcinoma with Portal Vein Invasion: a Randomized Clinical Trial. JAMA Oncol. 2019;5(7):953–60.

Article  PubMed  PubMed Central  Google Scholar 

Li QJ, He MK, Chen HW, et al. Hepatic arterial infusion of Oxaliplatin, Fluorouracil, and Leucovorin Versus Transarterial Chemoembolization for large Hepatocellular Carcinoma: a Randomized Phase III Trial. J Clin Oncol. 2022;40(2):150–60.

Article  CAS  PubMed  Google Scholar 

Zhang H, Zeng X, Peng Y, Tan C, Wan X. Cost-effectiveness analysis of Hepatic Arterial Infusion Chemotherapy of Infusional Fluorouracil, Leucovorin, and Oxaliplatin Versus Transarterial chemoembolization in patients with large unresectable Hepatocellular Carcinoma. Front Pharmacol. 2022;13:849189.

Article  CAS  PubMed  PubMed Central  Google Scholar 

He MK, Le Y, Li QJ, et al. Hepatic artery infusion chemotherapy using mFOLFOX versus transarterial chemoembolization for massive unresectable hepatocellular carcinoma: a prospective non-randomized study. Chin J Cancer. 2017;36(1):83.

Article  PubMed  PubMed Central  Google Scholar 

Rabe C, Lenz M, Schmitz V, et al. An independent evaluation of modern prognostic scores in a central European cohort of 120 patients with hepatocellular carcinoma. Eur J Gastroenterol Hepatol. 2003;15(12):1305–15.

Article  PubMed  Google Scholar 

Faria SC, Szklaruk J, Kaseb AO, Hassabo HM, Elsayes KM, TNM/Okuda/Barcelona. /UNOS/CLIP International Multidisciplinary Classification of Hepatocellular Carcinoma: concepts, perspectives, and radiologic implications. Abdom Imaging. 2014;39(5):1070–87.

Article  PubMed  Google Scholar 

Hsu CY, Hsia CY, Huang YH, et al. Selecting an optimal staging system for hepatocellular carcinoma: comparison of 5 currently used prognostic models. Cancer. 2010;116(12):3006–14.

Article  PubMed  Google Scholar 

Zeng Q, Xue N, Dai D, et al. A Nomogram based on inflammatory factors C-Reactive protein and fibrinogen to predict the Prognostic Value in patients with Resected Non-small Cell Lung Cancer. J Cancer. 2017;8(5):744–53.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li L, Zeng Q, Xue N, et al. A Nomogram based on Aspartate Aminotransferase/Alanine Aminotransferase (AST/ALT) ratio to predict prognosis after surgery in gastric Cancer patients. Cancer Control. 2020;27(1):1073274820954458.

Article  PubMed  PubMed Central  Google Scholar 

Li SQ, Zhang KC, Li JY, et al. Establishment and validation of a nomogram to predict the risk of ovarian metastasis in gastric cancer: based on a large cohort. World J Clin Cases. 2020;8(19):4331–41.

Article  PubMed  PubMed Central  Google Scholar 

Yu DD, Dong H, Chen WK, et al. Development and validation of a nomogram for predicting survival in patients with non-metastatic primary adenocarcinoma of the bladder. Transl Cancer Res. 2020;9(9):5155–65.

Article  PubMed  PubMed Central  Google Scholar 

Zhang S, Lu Y, Liu Z, Li X, Wang Z, Cai Z. Identification six metabolic genes as potential biomarkers for lung adenocarcinoma. J Comput Biol. 2020;27(10):1532–43.

Article  CAS  PubMed  Google Scholar 

Cao X, Wang HM, Lu R, et al. Establishment and verification of a nomogram for predicting severe acute pancreatitis. Eur Rev Med Pharmacol Sci. 2021;25(3):1455–61.

CAS  PubMed  Google Scholar 

Chen X, Guo T. Development of a nomogram for predicting survival of patients with ovarian serous cystadenocarcinoma after based on SEER database. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2021;50(3):369–74.

PubMed  PubMed Central  Google Scholar 

Zhao F, Liu Y, Gu X, Zhang B, Song C, Cui B. Identification of sixteen metabolic genes as potential biomarkers for colon adenocarcinoma. J BUON. 2021;26(4):1252–9.

PubMed  Google Scholar 

Zhang L, Shi FY, Qin Q, et al. [Relationship between preoperative inflammatory indexes and prognosis of patients with rectal cancer and establishment of prognostic nomogram prediction model]. Zhonghua Zhong Liu Za Zhi. 2022;44(5):402–9.

CAS  PubMed  Google Scholar 

Zhang Z, Liu Y, Ma G, Su J. A Nomogram Model for evaluating the risk of Lymph Node Metastasis in cT2-cT4N0M0 gastric Cancer Population. Med Sci Monit. 2022;28:e935696.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hermanek P, Wittekind C. Residual tumor (R) classification and prognosis. Semin Surg Oncol. 1994;10(1):12–20.

Article  CAS  PubMed  Google Scholar 

Zhou H, Song T. Conversion therapy and maintenance therapy for primary hepatocellular carcinoma. Biosci Trends. 2021;15(3):155–60.

Article  CAS  PubMed  Google Scholar 

Simcock R, Wright J. Beyond performance status. Clin Oncol (R Coll Radiol). 2020;32(9):553–61.

Article  CAS  PubMed  Google Scholar 

Kudo M, Kawamura Y, Hasegawa K, et al. Management of Hepatocellular Carcinoma in Japan: JSH Consensus statements and recommendations 2021 Update. Liver Cancer. 2021;10(3):181–223.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lyu N, Wang X, Li JB, et al. Arterial chemotherapy of Oxaliplatin Plus Fluorouracil Versus Sorafenib in Advanced Hepatocellular Carcinoma: a biomolecular exploratory, randomized, phase III trial (FOHAIC-1). J Clin Oncol. 2022;40(5):468–80.

Article  PubMed  Google Scholar 

Hu Z, Yang Z, Pan Y, et al. Survival benefit of preoperative hepatic arterial infusion of oxaliplatin, fluorouracil, and leucovorin followed by hepatectomy for hepatocellular carcinoma. Front Pharmacol. 2023;14:1210835.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhang H, Li G, Zhu Z, et al. Serum bilirubin level predicts postoperative overall survival in oral squamous cell carcinoma. J Oral Pathol Med. 2018;47(4):382–7.

Article  CAS  PubMed  Google Scholar 

Xu XS, Miao RC, Zhang LQ, et al. Model based on Alkaline phosphatase and Gamma-Glutamyltransferase for Gallbladder Cancer Prognosis. Asian Pac J Cancer Prev. 2015;16(15):6255–9.

Article  PubMed  Google Scholar 

Tian ZY, Li AM, Chu L, Hu J, Xie X, Zhang H. Prognostic value of low-density lipoprotein cholesterol in IgA nephropathy and establishment of nomogram model. Front Endocrinol (Lausanne). 2023;14:1037773.

Article  PubMed  Google Scholar 

Bangalore S, Fayyad R, Kastelein JJ, et al. 2013 cholesterol guidelines revisited: percent LDL cholesterol reduction or attained LDL cholesterol level or both for prognosis? Am J Med. 2016;129(4):384–91.

Article  CAS  PubMed